The NMDA Receptor Antagonist Memantine Modulates Aging and Stress Resilience
Aging Cell · 2026
DOI: 10.1111/acel.70303 ↗Kurz gefasst
Fachartikel in der Zeitschrift Aging Cell, 2026. Verfasst von Vaida Juozaityte und 8 weiteren Autor:innen. Beteiligte Einrichtung: Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Memantine, Caenorhabditis elegans, Receptors, N-Methyl-D-Aspartate, Aging. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Lundbeck Foundation, Novo Nordisk Foundation, Novo Nordisk Fonden.
Abstract (Originalsprache)
Aging is associated with a progressive decline in physiological resilience, often linked to impaired stress responses and metabolic dysfunction. In Caenorhabditis elegans ( C. elegans ), caloric restriction (CR) and pharmacological interventions are widely used to dissect conserved longevity pathways. Here, we identify the N‐methyl‐D‐aspartate receptor (NMDAR) antagonist memantine as a novel modulator of lifespan and stress tolerance in C. elegans . Memantine, but not ketamine, extends median lifespan and reproductive lifespan, suggesting that the observed effects are not shared with ketamine at the tested concentration. Transcriptomic analysis revealed significant overlap between memantine‐treated animals and CR models, particularly eat‐2 mutants, implicating shared metabolic and longevity‐associated pathways. Functionally, memantine was found to reduce mitochondrial and oxidative stress, while enhancing β‐oxidation of fatty acids, and modifying behavioral responses to food cues, delaying food‐seeking behavior and increasing locomotion under starvation, without affecting lipid storage. In summary, these findings suggest that memantine promotes stress resilience and healthy aging via metabolic changes that overlap with CR‐associated pathways, highlighting its potential as a longevity‐modulating intervention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
- Biotech Research and Innovation Center (BRIC), Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
ORCID-Profile: Steffen Abay-Nørgaard, Rebecca L McIntyre, Christoffer Clemmensen
Förderung
- Lundbeck Foundation
- Novo Nordisk Foundation
- Novo Nordisk Fonden
Zitieren
APA
Juozaityte, V., Pregnolato, C., Abay-Nørgaard, S., Rausch, D. M., McIntyre, R. L., Gerhart-Hines, Z., Pers, T. H., Salcini, A. E., & Clemmensen, C. (2026). The NMDA Receptor Antagonist Memantine Modulates Aging and Stress Resilience. Aging Cell. https://doi.org/10.1111/acel.70303
Vancouver
Juozaityte V, Pregnolato C, Abay-Nørgaard S, Rausch DM, McIntyre RL, Gerhart-Hines Z, et al. The NMDA Receptor Antagonist Memantine Modulates Aging and Stress Resilience. Aging Cell. 2026. doi:10.1111/acel.70303
BibTeX
@article{Juozaityte2026,
author = {Juozaityte, Vaida and Pregnolato, Chiara and Abay-Nørgaard, Steffen and Rausch, Dylan Matthew and McIntyre, Rebecca L and Gerhart-Hines, Zachary and Pers, Tune H and Salcini, Anna Elisabetta and Clemmensen, Christoffer},
title = {The NMDA Receptor Antagonist Memantine Modulates Aging and Stress Resilience},
journal = {Aging Cell},
year = {2026},
doi = {10.1111/acel.70303}
}
EUVIMED